PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

The summary for the PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]): This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2017-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA.

Federal Grant Title:	PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Environment Food and Nutrition Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-17-302
Type of Funding:	Grant
CFDA Numbers:	93.061, 93.068, 93.073, 93.084, 93.103, 93.113, 93.121, 93.136, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.316, 93.326, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 5th, 2018
Original Application Deadline:	January 5th, 2018
Posted Date:	June 5th, 2017
Creation Date:	June 5th, 2017
Archive Date:	February 10th, 2018
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	June 5th, 2017

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-17-302.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS); • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...; • Cdc Public Health Research: Health Protection Research Initiative Graduate Training Progra...; • Improving Public Health Practice through Translation Research (R18); • CDC Health Protection Research Initiative: Evaluation of Workplace Health Promotion Resear...
More Grants from the National Institutes of Health: • Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...; • Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...; • Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/...; • Biomedical Research Facilities (C06 Clinical Trial Not Allowed); • Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the ...